New York State Common Retirement Fund’s Lucid Diagnostics LUCD Stock Holding History

New York State Common Retirement Fund’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.5K	Hold	58,700	–	–	﹤0.01%	2709
2025 Q4	$64K	Hold	58,700	–	–	﹤0.01%	2828
2025 Q3	$59.3K	Sell	58,700 -25,400	-30%	-$27.7K	﹤0.01%	2893
2025 Q2	$96.7K	Buy	+84,100	New	+$109K	﹤0.01%	2699
2022 Q3	–	Sell	-48	Closed	–	–	3378
2022 Q2	$0	Sell	48 -13,752	-100%	-$30.6K	﹤0.01%	3515
2022 Q1	$46K	Hold	13,800	–	–	﹤0.01%	3186
2021 Q4	$74K	Buy	+13,800	New	+$112K	﹤0.01%	3150

Other funds holding LUCD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

New York State Common Retirement Fund's LUCD Position: Q1 2026 in Review

New York State Common Retirement Fund held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 58,700 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

New York State Common Retirement Fund first reported a position in LUCD in Q4 2021 and has held it in 7 quarters since. The position peaked at $96.7K in Q2 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

New York State Common Retirement Fund held 58,700 shares of Lucid Diagnostics worth $67.5K as of Q1 2026.
New York State Common Retirement Fund left its Lucid Diagnostics share count unchanged in Q1 2026.
Lucid Diagnostics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2709 holding.
New York State Common Retirement Fund first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 7 quarters since.
New York State Common Retirement Fund's Lucid Diagnostics position peaked at $96.7K in Q2 2025.
103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.